1. Home
  2. HOWL vs AKYA Comparison

HOWL vs AKYA Comparison

Compare HOWL & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • AKYA
  • Stock Information
  • Founded
  • HOWL 2017
  • AKYA 2015
  • Country
  • HOWL United States
  • AKYA United States
  • Employees
  • HOWL N/A
  • AKYA N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • AKYA Medical Specialities
  • Sector
  • HOWL Health Care
  • AKYA Industrials
  • Exchange
  • HOWL Nasdaq
  • AKYA Nasdaq
  • Market Cap
  • HOWL 53.8M
  • AKYA 56.1M
  • IPO Year
  • HOWL 2021
  • AKYA 2021
  • Fundamental
  • Price
  • HOWL $1.21
  • AKYA $1.26
  • Analyst Decision
  • HOWL Strong Buy
  • AKYA Hold
  • Analyst Count
  • HOWL 3
  • AKYA 7
  • Target Price
  • HOWL $8.33
  • AKYA $2.51
  • AVG Volume (30 Days)
  • HOWL 490.7K
  • AKYA 265.5K
  • Earning Date
  • HOWL 08-07-2025
  • AKYA 08-04-2025
  • Dividend Yield
  • HOWL N/A
  • AKYA N/A
  • EPS Growth
  • HOWL N/A
  • AKYA N/A
  • EPS
  • HOWL N/A
  • AKYA N/A
  • Revenue
  • HOWL $1,143,000.00
  • AKYA $79,961,000.00
  • Revenue This Year
  • HOWL N/A
  • AKYA $7.26
  • Revenue Next Year
  • HOWL N/A
  • AKYA $11.44
  • P/E Ratio
  • HOWL N/A
  • AKYA N/A
  • Revenue Growth
  • HOWL N/A
  • AKYA N/A
  • 52 Week Low
  • HOWL $0.60
  • AKYA $0.93
  • 52 Week High
  • HOWL $4.18
  • AKYA $3.42
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 51.44
  • AKYA 52.71
  • Support Level
  • HOWL $1.19
  • AKYA $1.21
  • Resistance Level
  • HOWL $1.35
  • AKYA $1.35
  • Average True Range (ATR)
  • HOWL 0.13
  • AKYA 0.08
  • MACD
  • HOWL -0.02
  • AKYA 0.01
  • Stochastic Oscillator
  • HOWL 21.84
  • AKYA 60.71

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About AKYA Akoya BioSciences Inc.

Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.

Share on Social Networks: